Immediate Impact
31 standout
Citing Papers
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine
2024 Standout
Works of Kamel Laribi being referenced
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
2018
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kamel Laribi | 91 | 143 | 9 | 76 | 6 | 239 | |
| Tilly Varughese | 78 | 119 | 17 | 67 | 5 | 207 | |
| Davide Rapezzi | 48 | 40 | 5 | 33 | 8 | 200 | |
| Cheuk W. Yung | 115 | 51 | 126 | 24 | 10 | 280 | |
| F. Murphy | 21 | 40 | 5 | 68 | 9 | 295 | |
| J Maertens | 97 | 41 | 5 | 29 | 8 | 229 | |
| Donna Patton | 54 | 33 | 17 | 19 | 11 | 255 | |
| Karin S. Ku | 33 | 44 | 1 | 19 | 9 | 223 | |
| Brad J. Davis | 67 | 21 | 3 | 31 | 9 | 297 | |
| Elisa López‐Fernández | 10 | 53 | 1 | 59 | 10 | 255 | |
| Rémy Nyga | 84 | 35 | 10 | 81 | 9 | 211 |
All Works
Login with ORCID to disown or claim papers
Loading papers...